Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy
0 Views
administrator
07/09/23
Dr Karl Kilgore speaks to ecancer at the 2019 ASH meeting in Orlando about the real-world use of CAR T-cell therapy in medicare patients with non-Hodgkin lymphoma.
He describes this study which investigated the costs, outcomes and healthcare utilisation in these patients before and after they received CAR T-cell therapy, as well as their demographic and clinical characteristics.
Dr Kilgore emphasises that the results of this study strongly show that older patients with co-morbidities can be successfully treated with this type of therapy
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
-
Category
Show more
Facebook Comments
No comments found